BTNX


BTNX Inc. is a biotechnology company and a world leader in rapid, point-of-care diagnostics. They focus on innovation, research, development, and manufacturing of advanced in-vitro diagnostic tests for laboratories, clinics, hospitals, and physicians’ offices. The company also develops information technology systems to manage point-of-care diagnostic test results, with a strong emphasis on quality, regulatory compliance, and global distribution. BTNX offers a wide range of drug testing and harm reduction products, including rapid test strips for fentanyl, benzodiazepines, xylazine, nitazene, medetomidine, and other substances, as well as drug checking kits and solutions for harm reduction and public health initiatives.

Industries

biopharma
biotechnology
health-care
medical

Nr. of Employees

medium (51-250)

BTNX

Markham, Ontario, Canada, North America


Products

Xylazine lateral flow test strip (liquid/powder)

Dipstick lateral flow immunoassay for qualitative presumptive detection of xylazine in liquids and powders with a reported cut-off sensitivity of 1000 ng/mL; kit formats include strips, interpretation card and, for multi-test kits, buffer tubes and swabs. Intended for forensic/presumptive use (not an IVD).

Medetomidine lateral flow test strip (liquid/powder)

Dipstick lateral flow immunoassay for qualitative presumptive detection of medetomidine in liquids and powders with a reported cut-off sensitivity of 1000 ng/mL; supplied in high-count kits with interpretation card and instructions. Forensic/presumptive use only.

Benzodiazepine lateral flow test strip (liquid/powder)

Rapid visual lateral flow immunoassay for qualitative presumptive detection of benzodiazepines in liquids or powders with a stated cut-off concentration of 300 ng/mL; provided with interpretation resources and intended for forensic/presumptive screening.

Nitazene lateral flow test strip (liquid/powder)

Lateral flow immunoassay strip for qualitative presumptive detection of nitazene-class synthetic opioids in liquids and powders with a reported sensitivity around 2000 ng/mL; kits include test strips, microscoops and interpretation card for standardized sampling. Forensic/presumptive use only.

Fentanyl lateral flow test strip (liquid/powder)

Dipstick lateral flow immunoassay for qualitative presumptive detection of fentanyl and select analogues in liquids and powders with low reported cut-off sensitivities; intended for forensic or harm-reduction screening (not a clinical IVD).

Urinalysis reagent strips and automated urine analyzers

Reagent strip formats covering multiple parameters and reflectance-photometry urine analyzers with barcode and result storage/printing options for routine urinalysis in point-of-care and laboratory settings.

View All Products

Services

Mobile test image capture and workflow application

Cloud-connected mobile application for capture, machine-assisted interpretation, documentation and upload of rapid-test images to a central database to support point-of-care workflows.

Remote proctoring and supervised testing workflows

Remote web-based proctoring and supervised verification workflows to support diagnostic testing programs and supervised-use requirements.

Point-of-care deployment support and training

On-site and remote deployment resources including multilingual instructions, training materials, onboarding documentation and technical support for deployment of rapid diagnostic kits.

Expertise Areas

  • Point-of-care diagnostic test development
  • Lateral flow immunoassays for liquid and powder screening
  • Microfluidic disk-panel assay development
  • Reagent-strip readers and reflectance photometry
  • Show More (7)

Key Technologies

  • Lateral flow immunoassay
  • Microfluidic disk-panel testing
  • Reflectance photometry readers
  • Colorimetric and immunoassay reagent chemistry
  • Show More (5)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.